glp-1 agonist indications Drugs: Where We Are and Where We're Going — Summit Re GLP-1 Agonists Market Report 2025-2033,

Indication: Primarily used for chronic idiopathic constipation in adults especially when laxatives fail to provide adequate relief

Unlike injectable obesity drugs, which are peptides designed to mimic the appetite-controlling GLP-1 hormone, orforglipron is a small molecule pill that is easier to manufacture and package, said Kenneth Custer, president of Lilly's cardiometabolic health division

46 Drug-Drug Interactions: Saxagliptin is a strong CYP3A4 inhibitor, so its labeling recommends limiting saxagliptin to 2.5 mg daily in patients taking other strong CYP3A4 inhibitors, such as ketoconazole, based on the risk of increased saxagliptin levels

L., Gower, B., Allison, J

Common symptoms include: Nausea (affecting 1040% of patients) Vomiting Diarrhoea Constipation Abdominal discomfort or pain Reduced appetite These effects are usually mild to moderate and tend to diminish over several weeks as the body adjusts to the medicine